Transient receptor potential canonical channel 6 (TRPC6) is a potential therapeutic target for Alzheimer's disease (AD) and its expression is highly regulated by glucose concentration. The gene discussed is TRPC6; the disease is early-onset autosomal dominant Alzheimer disease.